Submitted by Anonymous (not verified) on 22 January 2025 - 11:24
Human medicines European public assessment report (EPAR): Inlyta, axitinib, Date of authorisation: 03/09/2012, Revision: 17, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Inlyta, axitinib, Date of authorisation: 03/09/2012, Revision: 17, Status: Authorised